Betterlife Pharma Stock Probability of Future OTC Stock Price Finishing Over 8.62
| BETRF Stock | USD 0.08 0.01 9.59% |
BetterLife |
BetterLife Pharma Target Price Odds to finish over 8.62
The tendency of BetterLife OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 8.62 or more in 90 days |
| 0.08 | 90 days | 8.62 | close to zero percent |
Based on a normal probability distribution, the odds of BetterLife Pharma to move over $ 8.62 or more in 90 days from now is close to zero percent (This BetterLife Pharma probability density function shows the probability of BetterLife OTC Stock to fall within a particular range of prices over 90 days) . Probability of BetterLife Pharma price to stay between its current price of $ 0.08 and $ 8.62 at the end of the 90-day period is about 74.87 .
Assuming the 90 days horizon BetterLife Pharma has a beta of 0.78 suggesting as returns on the market go up, BetterLife Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding BetterLife Pharma will be expected to be much smaller as well. Additionally BetterLife Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. BetterLife Pharma Price Density |
| Price |
Predictive Modules for BetterLife Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BetterLife Pharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BetterLife Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BetterLife Pharma is not an exception. The market had few large corrections towards the BetterLife Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BetterLife Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BetterLife Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.78 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.01 |
BetterLife Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BetterLife Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BetterLife Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BetterLife Pharma had very high historical volatility over the last 90 days | |
| BetterLife Pharma has some characteristics of a very speculative penny stock | |
| BetterLife Pharma has high likelihood to experience some financial distress in the next 2 years | |
| BetterLife Pharma has accumulated 34.56 K in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. BetterLife Pharma has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BetterLife Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, BetterLife Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BetterLife Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BetterLife to invest in growth at high rates of return. When we think about BetterLife Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (12.16 M) with loss before overhead, payroll, taxes, and interest of (22.81 K). | |
| BetterLife Pharma has accumulated about 14.41 K in cash with (11.2 M) of positive cash flow from operations. |
BetterLife Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BetterLife OTC Stock often depends not only on the future outlook of the current and potential BetterLife Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BetterLife Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 85.2 M |
BetterLife Pharma Technical Analysis
BetterLife Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. BetterLife OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BetterLife Pharma. In general, you should focus on analyzing BetterLife OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
BetterLife Pharma Predictive Forecast Models
BetterLife Pharma's time-series forecasting models is one of many BetterLife Pharma's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BetterLife Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about BetterLife Pharma
Checking the ongoing alerts about BetterLife Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BetterLife Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BetterLife Pharma had very high historical volatility over the last 90 days | |
| BetterLife Pharma has some characteristics of a very speculative penny stock | |
| BetterLife Pharma has high likelihood to experience some financial distress in the next 2 years | |
| BetterLife Pharma has accumulated 34.56 K in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. BetterLife Pharma has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BetterLife Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, BetterLife Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BetterLife Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BetterLife to invest in growth at high rates of return. When we think about BetterLife Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (12.16 M) with loss before overhead, payroll, taxes, and interest of (22.81 K). | |
| BetterLife Pharma has accumulated about 14.41 K in cash with (11.2 M) of positive cash flow from operations. |
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.